Yeah it really depends on the size of the trial as well. From memory, Retts had 150 patient enrolment but PMS so far is less diagnosed and much smaller patient pool. I would be surprised FDA would require the same amount of patient enrolment. Say it's halved to 75, it sure can speed things up
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)